Asia-Pacific Autoimmune Diagnostics Market by Test type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others), by Disease - (Localized auto immune disease diagnostics (Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others), Systemic auto immune disease diagnostics(Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis)) by End users - (Hospitals, Research centres, Diagnostic laboratories) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Autoimmune Diagnostics Market by Test type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others), by Disease - (Localized auto immune disease diagnostics (Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others), Systemic auto immune disease diagnostics(Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis)) by End users - (Hospitals, Research centres, Diagnostic laboratories) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1193 | Pages: 134 | December 2016 | Region: Asia Pacific


The Asia - Pacific Autoimmune Diagnostics Market was worth $ 2.09billion in 2016 and estimated to reach $ 2.54 billion by the end of 2021 with a growing potential of 4.00%. Asia Pacific is predicted to witness promising growth over the next five years. Constantly improving patient awareness levels and healthcare infrastructure in the evolving markets of India and China have opened up new avenues for the manufacturers to capitalize on.

Autoimmune diseases is a hyper active immune response against its own body tissues and cells. Successful autoimmune disease awareness campaigns are boosting patients to seek clinical diagnostics even for symptoms such as gastrointestinal distress and fatigue. The rising incidence of primarily celiac disease, gastrointestinal autoimmune conditions also promotes testing.

Asia – Pacific market is mainly driven by High occurrence of auto immune disorders, increasing public awareness, improving healthcare infrastructure, increasing population. The key restraints that inhibiting the growth of the auto immune diagnostics market are high cost of treatment, growing rate of diagnostics errors and unavailability of skilled labour.

The Asia - Pacific Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.

Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’  disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis.

Based on End users into Hospitals, Research centres, and diagnostic laboratories and on the basis of geography, the Asia - Pacific Auto Immune Diagnostics market is analysed under various regions namely Japan, China, India and Australia.

Some of the key players influencing the Asia – Pacific Autoimmune diagnostics market are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Feed Mineral Market By Region, From 2016-2021 (USD Billion)
  2. Asia-Pacific Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  3. Asia-Pacific Autoantibody Tests Market By Region, From 2016-2021 (USD Billion)
  4. Asia-Pacific Antinuclear Antibody Tests Market By Region, From 2016-2021 (USD Billion)
  5. Asia-Pacific Complete Blood Count (CBC) Market By Region, From 2016-2021 (USD Billion)
  6. Asia-Pacific C - reactive protein (CRP) Market By Region, From 2016-2021 (USD Billion)
  7. Asia-Pacific Comprehensive Metabolic panel Market By Region, From 2016-2021 (USD Billion)
  8. Asia-Pacific Urinalysis Market By Region, From 2016-2021 (USD Billion)
  9. Asia-Pacific Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2016-2021 (USD Billion)
  10. Asia-Pacific Other Test Types Market By Region, From 2016-2021 (USD Billion)
  11. Asia-Pacific Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  12. Asia-Pacific Localized Autoimmune Diseases Diagnostics Market By Region, From 2016-2021 (USD Billion)
  13. Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market By Region, From 2016-2021 (USD Billion)
  14. China Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  15. China Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  16. India Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  17. India Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  18. Japan Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  19. Japan Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  20. South Korea Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  21. South Korea Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  22. Australia Feed Mineral Market By Test Type, From 2016-2021 (USD Billion)
  23. Australia Feed Mineral Market By Disease Type, From 2016-2021 (USD Billion)
  24. Asia-Pacific Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  25. Asia-Pacific Graves' Disease Market By Region, From 2016-2021 (USD Billion)
  26. Asia-Pacific Hashimoto's Thyroiditis Market By Region, From 2016-2021 (USD Billion)
  27. Asia-Pacific Multiple Sclerosis Market By Region, From 2016-2021 (USD Billion)
  28. Asia-Pacific Type 1 diabetes Market By Region, From 2016-2021 (USD Billion)
  29. Asia-Pacific Psoriasis Market By Region, From 2016-2021 (USD Billion)
  30. Asia-Pacific Other Localized Autoimmune Diagnostics Market By Region, From 2016-2021 (USD Billion)
  31. China Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  32. India Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  33. Japan Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  34. South Korea Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  35. Australia Localized Autoimmune Disease Diagnostics Market By Type, From 2016-2021 (USD Billion)
  36. Asia-Pacific Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
  37. Asia-Pacific Rheumatoid Arthritis (RA) Market By Region, From 2016-2021 (USD Billion)
  38. Asia-Pacific Ankylosing Spondylitis Market By Region, From 2016-2021 (USD Billion)
  39. Asia-Pacific Systemic Lupus Erythematosus (SLE) Market By Region, From 2016-2021 (USD Billion)
  40. China Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
  41. India Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
  42. Japan Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
  43. South Korea Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
  44. Australia Systemic Auto-immune disease diagnostics Market By Type, From 2016-2021 (USD Billion)
Middle-East And Africa Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], ...
Latin America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Asia-Pacific Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (...
Europe Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharma...
North America Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User ...
Cell Counting Market By Product [(Instruments (Cell Counters, Hematology Analysers, Spectrophotometer, Flow Cytometer, Hemocytometer, Others), Consumables (Microplates, Reagent, Assay Kits)], End User (Pharmaceutica...
Middle East And Africa Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid T...
Latin America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And ...
Europe Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others...
North America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others) And B...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.